PARLIAMENTARY WRITTEN QUESTION
Dinutuximab Beta (13 June 2018)

Question Asked

To ask the Secretary of State for Health and Social Care, what discussions his Department has had with NICE on the availability of Dinutuximab Beta on the NHS.

Asked by:
Helen Hayes (Labour)

Answer

Departmental officials regularly discuss a range of issues with colleagues in the National Institute for Health and Care Excellence, and have had a number of discussions about the ongoing technology appraisal of dinutuximab beta for the treatment of high-risk neuroblastoma.


Answered by:
Steve Brine (Conservative)
21 June 2018

Contains Parliamentary information licensed under the Open Parliament Licence v3.0.